Skip to main content
OpenTrials

Clinical trial condition

Hypereosinophilic Syndrome

Explore clinical trials studying Hypereosinophilic Syndrome. Study availability and eligibility vary by location and protocol.

31 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Hypereosinophilic Syndrome trial results

Completed

Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)

NCT04965636

Conditions
Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • GSK Investigational Site Rochester, Minnesota, United States
  • GSK Investigational Site Cincinnati, Ohio, United States
  • GSK Investigational Site Cleveland, Ohio, United States
  • GSK Investigational Site Charleston, South Carolina, United States
View all 14 locations
View Trial Details
Completed

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

NCT00109707

Conditions
Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Bone Marrow Diseases, Chronic Disease, +27 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • H. Lee Moffitt Cancer Center & Research Institute Dept.of H. Lee Moffitt Tampa, Florida, United States
View all 101 locations
View Trial Details
Completed

A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622

NCT03306043

Conditions
Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • GSK Investigational Site La Jolla, California, United States
  • GSK Investigational Site New Haven, Connecticut, United States
  • GSK Investigational Site Rochester, Minnesota, United States
  • GSK Investigational Site Cincinnati, Ohio, United States
View all 36 locations
View Trial Details

Related conditions